Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells

Published:2019-01-31 Issue:2 Volume:42 Page:223-235
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Kokabu Tetsuya,Mori Taisuke,Matsushima Hiroshi,Yoriki Kaori,Kataoka Hisashi,Tarumi Yosuke,Kitawaki Jo

Funder

Ministry of Education, Culture, Sports, Science, and Technology of Japan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s13402-019-00423-5/fulltext.html

Reference62 articles.

1. J. Lortet-Tieulent, J. Ferlay, F. Bray, A. Jemal, International patterns and trends in endometrial Cancer incidence, 1978–2013. J Natl Cancer Inst 110, 354–361 (2017)

2. T. Odagiri, H. Watari, M. Hosaka, T. Mitamura, Y. Konno, T. Kato, N. Kobayashi, S. Sudo, M. Takeda, M. Kaneuchi, N. Sakuragi, Multivariate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol 22, 3–8 (2011)

3. C.E. Humber, J.F. Tierney, R.P. Symonds, M. Collingwood, J. Kirwan, C. Williams, J.A. Green, Chemotherapy for advanced, recurrent or metastatic endometrial cancer: A systematic review of Cochrane collaboration. Ann Oncol 18, 409–420 (2007)

4. G. Altwerger, E. Bonazzoli, S. Bellone, T. Egawa-Takata, G. Menderes, F. Pettinella, A. Bianchi, F. Riccio, J. Feinberg, L. Zammataro, C. Han, G. Yadav, K. Dugan, A. Morneault, J.F. Ponte, N. Buza, P. Hui, S. Wong, B. Litkouhi, E. Ratner, D.A. Silasi, G.S. Huang, M. Azodi, P.E. Schwartz, A.D. Santin, In vitro and in vivo activity of IMGN853, an antibody-drug conjugate targeting folate receptor alpha linked to DM4. in biologically aggressive endometrial cancers Mol Cancer Ther 17, 1003–1011 (2018)

5. F. Simpkins, R. Drake, P.F. Escobar, B. Nutter, N. Rasool, P.G. Rose, A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA). Gynecol Oncol 136, 240–245 (2015)

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy;Cell Reports Medicine;2024-08

2. The Role of Estrogen across Multiple Disease Mechanisms;Current Issues in Molecular Biology;2024-07-29

3. Estrogen related receptor alpha: Potential modulator of age-related macular degeneration;Current Opinion in Pharmacology;2024-04

4. Estrogen-related receptor alpha: A novel perspective on skeletal, muscular, and vascular systems;BIOCELL;2024

5. Research Progress of Estrogen Receptor in Ovarian Cancer;Clinical and Experimental Obstetrics & Gynecology;2023-09-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3